NL
DE
Our purpose
The overarching aim is to develop novel pharmacotherapeutic treatment strategies and technologies, from a societal perspective.
Goals
- Creation of an academic drug development ecosystem.
- Disseminate academic drug development knowledge.
- Develop novel pharmacotherapeutic and repurpose treatments.
- To develop alternative and optimized dosing strategies for existing treatments.
- To develop novel model-informed dosing and drug development methodologies.
- To develop novel drug production platform technologies for cell therapy, drug delivery and gene modulation.
- To develop affordable and accessible pharmacotherapeutic treatments.
- Guide Understanding the consequences of stress exposure at multiple scales from molecules to neurocognitive systems to behavior, both in animals and humans, to identify mechanisms and determinants of resilience and vulnerability.
- Regulatory decision making on (academic) drug development.
Research group leaders
See which research group leaders (RGLs) contribute to this research program.
read moreResearch group leaders
Our programs form inspiring environments in which research groups work together toward a common and clear goal, enabling our researchers to strenghten collaboration and cross thematic and disciplinary boundaries. Within and outside Radboudumc.
RGLs contributing to this research program
- Rob Aarnoutse
- Roger Brüggemann
- David Burger
- Nielka van Erp
- Marien de Jonge
- Frans Russel
- Jolanda de Vries
- Saskia de Wildt
- Carla van Herpen
- Elke de Jong
In the near future, we plan to link specially designed research group pages instead of these profile pages.
